Wissenschaftliche Arbeiten

Prof. Dr. Faysal Dane

278 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Impact of body mass index on cancer development.

    PubMed, 2008

    PMID 18404787 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  2. Preoperative radiotherapy with concomitant fluoropyrimidine-based chemotherapy for resectable locally advanced rectal cancer

    DergiPark (Istanbul University), 2008

    Quelle: OpenAlex

  3. Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.14588 Quelle: OpenAlex

  4. Clinical outcome of node-negative (NN) breast cancer (BC) patients

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.11102 Frei zugänglicher VolltextQuelle: OpenAlex

  5. P2-323: Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

    Journal of Thoracic Oncology, 2007

    DOI 10.1097/01.jto.0000284031.87598.62 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival

    Oncology, 2007

    DOI 10.1159/000111118 PMID 18025805 40 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  7. The role of adjuvant chemoradiotherapy (CRT) in Turkish patients with gastric carcinoma

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.15159 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Clinical outcome of node-negative (NN) breast cancer (BC) patients

    Kocaeli Üniversitesi - AVESİS, 2007

    Quelle: OpenAlex

  9. The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study

    Dspace Repository (Marmara Üniversitesi), 2006

    10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.24.18_suppl.13584 Quelle: OpenAlex

  11. Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience

    Kocaeli Üniversitesi - AVESİS, 2006

    Quelle: OpenAlex

  12. Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital

    Kocaeli Üniversitesi - AVESİS, 2006

    Quelle: OpenAlex

  13. Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

    Kocaeli Üniversitesi - AVESİS, 2006

    Quelle: OpenAlex

  14. Tolerability assessment of urasil-tegafur (UFT)/folinic acid (FA) as concurrent chemoradiation (CRT) in adjuvant rectal cancer treatment

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.24.18_suppl.13559 Quelle: OpenAlex

  15. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.

    Journal of experimental & clinical cancer research : CR, 2006

    PMID 17310842 74 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  16. Adjuvant comcomittant administration of urasil-tegafur (UFT) and folinic acid (FA) during irradiation for locally advanced rectum cancer: Tolerability assessment

    Dspace Repository (Marmara Üniversitesi), 2006

    Frei zugänglicher VolltextQuelle: OpenAlex

  17. Stage I (T1N0M0) breast cancer (BC): Pathological characteristics and clinical outcome

    Kocaeli Üniversitesi - AVESİS, 2006

    Quelle: OpenAlex

  18. What is the Optimal Number of Lymph Nodes to be Dissected in Colorectal Cancer Surgery?

    Tumori Journal, 2005

    DOI 10.1177/030089160509100212 PMID 15948546 14 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival

    Journal of Clinical Oncology, 2005

    DOI 10.1200/jco.2005.23.16_suppl.4040 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Outcome of adjuvant treatment in elderly Turkish breast cancer patients

    Journal of Clinical Oncology, 2005

    DOI 10.1200/jco.2005.23.16_suppl.896 Frei zugänglicher VolltextQuelle: OpenAlex

  21. The prognostic impact of body mass index (BMI) in early breast cancer (BC) patients (pts)

    Journal of Clinical Oncology, 2005

    DOI 10.1200/jco.2005.23.16_suppl.882 Quelle: OpenAlex

  22. Clinical and pathological characteristics of early breast cancer (EBC) patients

    Journal of Clinical Oncology, 2005

    DOI 10.1200/jco.2005.23.16_suppl.887 Frei zugänglicher VolltextQuelle: OpenAlex

  23. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients

    International Journal of Colorectal Disease, 2004

    DOI 10.1007/s00384-004-0613-5 PMID 15293062 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  24. Does the incidence of anal canal cancers differ in Moslem societies?

    International Journal of Colorectal Disease, 2004

    DOI 10.1007/s00384-004-0614-4 PMID 15293063 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Human papilloma virus: Is it a new etiological factor in breast cancer?

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.9635 Frei zugänglicher VolltextQuelle: OpenAlex

  26. Is the incidence of anal canal cancers different in Moslem societies?

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.4233 Frei zugänglicher VolltextQuelle: OpenAlex

  27. FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.3729 Frei zugänglicher VolltextQuelle: OpenAlex

  28. Evre I (T1N0M0) meme kanseri: patolojik özellikler ve klinik sonuçlar.

    2004

    Quelle: OpenAlex